Holen Sie sich die Stockscreener-App
0.72
8.33%
-0.0654
Handel nachbörslich:
.72
Schlusskurs vom Vortag:
$0.7854
Offen:
$0.79
24-Stunden-Volumen:
922.24K
Relative Volume:
0.61
Marktkapitalisierung:
$19.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-28.00%
1M Leistung:
-87.14%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.7053
$0.79
1-Wochen-Bereich:
$0.662
$1.05
52-Wochen-Spanne:
$0.662
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Firmenname
Curanex Pharmaceuticals Inc
Sektor
Branche
Telefon
718-673-6078
Adresse
2 JERICHO PLAZA,, JERICHO
Vergleichen Sie CURX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.72 | 22.24M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Curanex Pharmaceuticals Issues Shares Post-IPO - TipRanks
Curanex Pharmaceuticals issues shares in private placement and repays insider loans - Investing.com
Curanex Pharmaceuticals Inc’s Quiet Period To End on October 6th (NASDAQ:CURX) - Defense World
RXRX Stock Surges: What’s Next? - StocksToTrade
CURX Pharmaceuticals: A New Dawn or a Passing Surge? - StocksToTrade
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.57% - Investing.com India
Chinese Stocks To Follow Now – September 11th - Defense World
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale - TipRanks
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters - GlobeNewswire
$17.25M IPO Complete: Biotech Curanex Pharmaceuticals Secures Full Over-Allotment Exercise at $4/Share - Stock Titan
Biopharma IPO activity slows, but 2025 returns are surging - BioWorld MedTech
Finance Watch: Ever The Outlier, Biotech Outpaces Broader Stocks - insights.citeline.com
Chinese Stocks To Watch Today – September 2nd - Defense World
Chinese Stocks To Watch Today – August 31st - Defense World
Chinese Stocks To Watch TodayAugust 31st - MarketBeat
Promising Chinese Stocks To ConsiderAugust 30th - MarketBeat
Chinese Stocks To Research – August 29th - Defense World
Wall Street Zen Upgrades Curanex Pharmaceuticals (NASDAQ:CURX) to “Hold” - Defense World
Curanex Pharmaceuticals (NASDAQ:CURX) Raised to “Hold” at Wall Street Zen - Defense World
IPO NewsUS IPO Weekly Recap: Quiet week as IPO market gears up for a busy fall - renaissancecapital.com
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ - Investing.com
Curanex Pharmaceuticals Inc. (CURX) Soars 10.52% on Successful IPO - AInvest
Curanex Pharmaceuticals shares rise 7.30% premarket after closing its initial public offering of 3,750,000 shares at $4.00 per share. - AInvest
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ By Investing.com - Investing.com Australia
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewswire
Curanex Pharmaceuticals' IPO: A Strategic Bet on Botanical Innovation in a Resilient Biotech Sector - AInvest
Curanex Pharmaceuticals Inc. announces closing of its initial public offering - MarketScreener
Curanex Pharmaceuticals Completes Initial Public Offering for $15 Million - AInvest
$15 Million IPO: Inflammatory Disease Biotech Curanex Launches on Nasdaq with Botanical Drug Focus - Stock Titan
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to NASDAQ Composite Index - MarketScreener
IPO Preview | Curanex Will be Listed on 8/26/2025 - AInvest
Curanex Pharmaceuticals prices IPO at $4 per share - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million By Investing.com - Investing.com South Africa
CURX Stock Price and Chart — NASDAQ:CURX - TradingView
Curanex Pharmaceuticals' Nasdaq Debut: A Cautious Bet on Botanical Innovation - AInvest
Curanex Pharmaceuticals Shares Fall in Nasdaq Debut - MarketScreener
CURX IPO NewsPreclinical biotech Curanex Pharmaceuticals prices IPO at $4, the low end of the range - renaissancecapital.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share By Investing.com - Investing.com UK
Curanex pharmaceuticals announces pricing of its initial public offering - MarketScreener
Curanex Pharmaceuticals announces pricing of IPO - AInvest
Finanzdaten der Curanex Pharmaceuticals Inc-Aktie (CURX)
Es liegen keine Finanzdaten für Curanex Pharmaceuticals Inc (CURX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):